Core Viewpoint - The company has received a drug registration certificate for Tadalafil 20mg tablets from the Ghana Food and Drug Administration, marking a significant step in its international market expansion [1][3]. Group 1: Drug Registration Details - Drug Name: TADALAFIL 20mg TABLETS - Dosage Form: Tablet - Specification: 20mg - Registration Number: FDA/GD.255-120251 - Certificate Number: FDA-GH-77157971 - Manufacturer: Jiangsu Lianhuan Pharmaceutical Co., Ltd. - Address: No. 9, Health Road, Yangzhou Biohealth Industry Park, Yangzhou, Jiangsu Province - Validity Period: Until December 31, 2030 [1]. Group 2: Market Position and Financial Impact - The company is the only Chinese enterprise holding the Tadalafil 20mg drug registration certificate in Ghana [2]. - The sales revenue for Tadalafil tablets in 2024 is projected to be 23.0793 million RMB [1]. - The registration allows for legal sales in Ghana, but the expected revenue impact on the company's overall performance is minimal due to the current lack of sales in the region [3].